Abdelzaher E, Mostafa MF (2015) Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence. Tumour Biol: J Int Soc Oncodev Biol Med 36:5473–5483

Article  CAS  Google Scholar 

Brastianos PK, Carter SL, Santagata S et al. (2015) Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov 5:1164–1177

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen G, Chakravarti N, Aardalen K et al. (2014) Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target. Clin Cancer Res: off J Am Assoc Cancer Res 20:5537–5546

Article  CAS  Google Scholar 

Dang CV (2012) MYC on the path to cancer. Cell 149:22–35

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dang Z, Xu WH, Lu P et al. (2014) MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma. Int J Biol Sci 10:733–745

Article  PubMed  PubMed Central  CAS  Google Scholar 

Du Y, Wang Q, Zhang X et al. (2017) Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma. J Experiment Clin Cancer Res: CR 36:66

Article  PubMed  PubMed Central  Google Scholar 

Grupp K, Sanader S, Sirma H et al. (2013) High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers. Mol Oncol 7:1001–1011

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hartkopf AD, Muller V, Wockel A et al. (2019) Translational highlights in breast and ovarian cancer 2019—immunotherapy, DNA repair, PI3K inhibition and CDK4/6 therapy. Geburtshilfe Frauenheilkd 79:1309–1319

Article  PubMed  PubMed Central  Google Scholar 

Hu J, Zhang L, Chen Q et al. (2018) Knockdown of CPEB4 expression suppresses cell migration and invasion via Akt pathway in non-small cell lung cancer. Cell Biol Int 42:1484–1491

Article  PubMed  CAS  Google Scholar 

Jiang Y, Wang Y, Wang T, Hawke D (2019) Inhibition of LPCAT1 inhibits cellular proliferation and motility in glioblastoma cells. J Cell Physiol 234:6267–6282. https://doi.org/10.1002/jcp.27429

Article  CAS  Google Scholar 

Lebok P, von Hassel A, Meiners J et al. (2019) Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer. Aging 11:7796–7804

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liang Q, Yao Q, Hu G (2019) CyclinD1 Is a new target gene of tumor suppressor MiR-520e in breast cancer. Open Med 14:913–919

Article  CAS  Google Scholar 

Ma L, Young J, Prabhala H et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12:247–256

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ma Z, Lou S, Jiang Z (2020) PHLDA2 regulates EMT and autophagy in colorectal cancer via the PI3K/AKT signaling pathway. Aging 12:7985–8000

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mansilla F, da Costa KA, Wang S et al. (2009) Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J Mol Med 87:85–97

Article  PubMed  CAS  Google Scholar 

Meyer N, Penn LZ (2008) Reflecting on 25 years with MYC. Nat Rev Cancer 8:976–990

Article  PubMed  CAS  Google Scholar 

Niessner H, Schmitz J, Tabatabai G et al. (2016) PI3K pathway inhibition achieves potent antitumor activity in melanoma brain metastases in vitro and in vivo. Clin Cancer Res: off J Am Assoc Cancer Res 22:5818–5828

Article  CAS  Google Scholar 

Ozretic P, Alvir I, Sarcevic B et al. (2018) Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients. Int J Biol Markers 33:109–115

Article  PubMed  CAS  Google Scholar 

Shida-Sakazume T, Endo-Sakamoto Y, Unozawa M et al. (2015) Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor. PLoS ONE 10:e0120143

Article  PubMed  PubMed Central  Google Scholar 

Tang M, Zhao Y, Liu N et al. (2017) Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway. J Cancer Res Clin Oncol 143:793–805

Article  PubMed  CAS  Google Scholar 

Yu X, Li Y, Jiang G et al. (2021) FGF21 promotes non-small cell lung cancer progression by SIRT1/PI3K/AKT signaling. Life Sci 269:118875

Article  PubMed  CAS  Google Scholar 

Zhuang C, Ma Q, Zhuang C, Ye J, Zhang F, Gui Y (2019) LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC. FASEB j: off Publ Fed Am Soc EXp Biol 33:11045–11059

Article  CAS  Google Scholar